Dr. Robert Gabbay has been named chief medical officer at Joslin Diabetes Center. Gabbay has led various projects investigating new models in health care in Pennsylvania, where he is director of the Penn State Institute for Diabetes and Obesity.
“We’re very excited and delighted to have Dr. Gabbay join Joslin,” chief executive John L. Brooks III said in a press release. “His extensive experience and leadership in developing and implementing innovative clinical improvements and programs will significantly contribute to Joslin’s ongoing efforts to address and impact the global diabetes epidemic.”
Gabbay studied medicine at SUNY Health Sciences Center-Brooklyn, after earning a Ph.D. in biochemistry at the University of Wisconsin, and later trained at Beth Israel Deaconess Medical Center.
Much of his research has focused on helping patients to optimally manage their diabetes and engage in their own care. Recently, he has led a program to design a new model of health care for the state of Pennsylvania, and he is a principal investigator for three projects funded by the US Agency for Healthcare Research and Quality to create patient-centered medical homes.
Gabbay is a professor of medicine at Pennsylvania State University College of Medicine.